# Emulation of the KEYNOTE-189 Trial Using Electronic Health Records

> **NCT05908799** · — · COMPLETED · sponsor: **Aetion, Inc.** · enrollment: 1854 (actual)

## Conditions studied

- Non-small Cell Lung Cancer
- Metastatic Lung Cancer

## Interventions

- **DRUG:** Pembrolizumab + Pemetrexed-Platinum
- **DRUG:** Pemetrexed-Platinum

## Key facts

- **NCT ID:** NCT05908799
- **Lead sponsor:** Aetion, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-05
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 1854 (ACTUAL)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05908799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05908799, "Emulation of the KEYNOTE-189 Trial Using Electronic Health Records". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05908799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*